Selling prescription drugs to the consumer: with Vioxx's withdrawal, new questions on a $3.8 billion ad business.
Stuart
S
Elliott
Nat
N
Ives
D000329:Advertising / Q000191:economics / Q000941:ethics* / Q000379:methods; D004345:Drug Industry / Q000191:economics*; D011307:Drug Prescriptions; D033161:Government Regulation; D004364:Pharmaceutical Preparations; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations